Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

May 27th, 2025 - Hedge Fund Investor Letters News

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025

No matter the market environment, you’ll always find entertainment in the biotech space.

Keep Reading →

March 1st, 2025 - Market Movers News

10 Best Immunology Stocks To Buy Now

Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.

Keep Reading →

February 28th, 2025 - Hedge Funds News

10 Best Performing Mid Cap Stocks to Buy According to Analysts

On February 7, Simeon Hyman, Global Investment Strategist at ProShares Advisors, appeared on CNBC to discuss the upcoming jobs report and its expected impact on the market.

Keep Reading →

February 25th, 2025 - Hedge Funds News

10 Best Performing Pharma Stocks So Far in 2025

On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may face under the new Trump...

Keep Reading →

February 22nd, 2025 - Hedge Funds Industries News

10 Best Performing Healthcare Stocks So Far in 2025

Despite the ongoing craze surrounding the GLP-1 obesity drugs, the healthcare sector was a lagger last year.

Keep Reading →

February 19th, 2025 - Hedge Funds Industries News

12 NASDAQ Stocks with Biggest Upside Potential According to Analysts

Potomac Wealth Advisors president Mark Avallone joined CNBC's 'The Exchange' on November 16 to discuss where he sees investing opportunities following Trump's election.

Keep Reading →

November 21st, 2024 - Hedge Funds News